Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | +2.87% | -10.50% | +566.67% |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Elevation Oncology, Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 196M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -60M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.93
x | P/E ratio 2025 * |
-4
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.82% |
1 day | +2.87% | ||
1 week | -10.50% | ||
Current month | +0.85% | ||
1 month | -22.84% | ||
3 months | +23.45% | ||
6 months | +623.23% | ||
Current year | +566.67% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 3.58 | +2.87% | 453,892 |
24-05-07 | 3.48 | -6.95% | 561,874 |
24-05-06 | 3.74 | +1.08% | 539,403 |
24-05-03 | 3.7 | -3.14% | 431,646 |
24-05-02 | 3.82 | -4.50% | 1,942,561 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+566.67% | 190M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- ELEV Stock